Company Filing History:
Years Active: 2022-2025
Title: Innovations of Johan Martin Brynolfsson
Introduction
Johan Martin Brynolfsson is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of artificial intelligence and medical imaging. With a total of four patents to his name, Brynolfsson is recognized for his innovative approaches to detecting and characterizing lesions in nuclear medicine images.
Latest Patents
Brynolfsson's latest patents focus on systems and methods for artificial intelligence-based image analysis. These innovations aim to improve the detection and characterization of lesions within a subject through automated analysis of nuclear medicine images, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) images. The patented systems leverage artificial intelligence to identify regions in 3D nuclear medicine images that correspond to hotspots indicative of potential cancerous lesions. The machine learning modules not only detect the presence and locations of these regions but also segment the lesions and classify the hotspots based on their likelihood of being true cancerous lesions. This AI-based approach provides a foundation for further characterization of lesions, overall tumor burden, and estimation of disease severity and risk.
Career Highlights
Brynolfsson is currently associated with Exini Diagnostics AB, where he continues to develop innovative solutions in medical imaging. His work has significantly advanced the capabilities of AI in healthcare, particularly in the early detection of cancer.
Collaborations
Some of his notable coworkers include Kerstin Elsa Maria Johnsson and Hannicka Maria Eleonora Sahlstedt. Their collaborative efforts contribute to the ongoing advancements in the field of medical imaging and artificial intelligence.
Conclusion
Johan Martin Brynolfsson's contributions to artificial intelligence and medical imaging have positioned him as a key figure in the detection and characterization of lesions. His innovative patents reflect a commitment to improving healthcare outcomes through technology.